Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells

被引:0
作者
J. Surówka
I. Wertel
K. Okła
W. Bednarek
R. Tarkowski
J. Kotarski
机构
[1] Medical University of Lublin,I Chair and Department of Oncological Gynaecology and Gynaecology
来源
Clinical and Translational Oncology | 2017年 / 19卷
关键词
Ovarian cancer; Dendritic cells; Regulatory T cells; Peritoneal fluid; Cell cultures;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1489 / 1497
页数:8
相关论文
共 143 条
[1]  
Chester C(2015)Immunotherapeutic approaches to ovarian cancer treatment J Immunother Cancer 24 3-7
[2]  
Dorigo O(2004)Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 1511-1518
[3]  
Berek JS(2016)The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded Am J Pathol 186 733-747
[4]  
Kohrt H(2014)Ovarian cancer biology and immunotherapy Int Rev Immunol 33 428-440
[5]  
IeM Shih(2015)Role of dendritic cells in the induction of lymphocyte tolerance Front Immunol 6 535-52
[6]  
RJ Kurman(2002)Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial Cancer Immunol Immunother 51 45-508
[7]  
Kurman RJ(2002)Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study J Immunother 25 500-4815
[8]  
I-M Shih(2013)Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo costimulated T-cells in recurrent ovarian cancer Oncoimmunology 2 e22664-929
[9]  
Latha TS(2013)A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside Clin Cancer Res 19 4801-949
[10]  
Panati K(2005)Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4 J Exp Med 202 919-5249